Cargando…

Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

BACKGROUND: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is a major global health problem. A few risk calculators have been developed using mainly HBV seromarkers as predictors. However, serum HBV DNA level, HBV genotype, and mutants are not routinely checked in regular health exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yu-Ju, Lee, Mei-Hsuan, Yang, Hwai-I, Jen, Chin-Lan, You, San-Lin, Wang, Li-Yu, Lu, Sheng-Nan, Liu, Jessica, Chen, Chien-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629190/ https://www.ncbi.nlm.nih.gov/pubmed/23613855 http://dx.doi.org/10.1371/journal.pone.0061448

Ejemplares similares

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
por: Lee, Mei-Hsuan, et al.
Publicado: (2017)

Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients
por: Liu, Jessica, et al.
Publicado: (2017)

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
por: Yang, Hwai-I, et al.
Publicado: (2008)

HBV genotype-dependent association of HLA variants with the serodecline of HBsAg in chronic hepatitis B patients
por: Chu, Yu-Ju, et al.
Publicado: (2023)

Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies
por: Lee, Mei-Hsuan, et al.
Publicado: (2014)

Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand: Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors
por: Luksamijarulkul, Pipat, et al.
Publicado: (2011)

Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk
por: Lee, Mei-Hsuan, et al.
Publicado: (2015)

Rubella Seromarkers among Children and Adolescent
por: Yasri, Sora, et al.
Publicado: (2017)

Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq
por: Al-Rubaye, Ali, et al.
Publicado: (2016)

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance
por: Huang, Chung-Feng, et al.
Publicado: (2017)

Analysis of Knowledge, Attitudes, and Prevalence of Hepatitis B and C Seromarkers Among Barbers in Tehran
por: Khairkhah, Tahereh, et al.
Publicado: (2016)

Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers
por: Hon, Kam Lun, et al.
Publicado: (2017)

Rapid Decline Rather Than Absolute Level of HBsAg Predicts Its Seroclearance in Untreated Chronic Hepatitis B Patients From Taiwanese Communities
por: Lin, Hsin-Che, et al.
Publicado: (2023)

Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers
por: Yamamoto, Chikako, et al.
Publicado: (2020)

A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements
por: Lin, Yu-Ju, et al.
Publicado: (2018)

A Study on Hepatitis B Viral Seromarkers and Associated Risk Factors among the Patients Suffering from Acute and Chronic Hepatitis B Infection
por: Prabina, P, et al.
Publicado: (2019)

Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma
por: Lu, Meng-Chuan, et al.
Publicado: (2023)

Prevalence of Hepatitis B Virus Seromarkers in Young Adults Vaccinated at Birth; Impact on the Epidemiology of Hepatitis B Infection in Iran
por: Saffar, Hiva, et al.
Publicado: (2014)

Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
por: Wu, Hui-Chen, et al.
Publicado: (2021)

Hepatitis B virus seromarkers among HIV infected adults on ART: An unmet need for HBV screening in eastern Ethiopia
por: Ayana, Desalegn Admassu, et al.
Publicado: (2019)

Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection
por: Chen, Hsuan-Wei, et al.
Publicado: (2020)

Fifteen-Year Population Attributable Fractions and Causal Pies of Risk Factors for Newly Developed Hepatocellular Carcinomas in 11,801 Men in Taiwan
por: Liao, Shu-Fen, et al.
Publicado: (2012)

Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B
por: Yu, Ming-Whei, et al.
Publicado: (2022)

Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B
por: Argirion, Ilona, et al.
Publicado: (2021)

Rubella Seromarkers and Determinants of Infection among Tanzanian Children and Adolescents in Prevaccination Era: Are We in the Right Track?
por: Mirambo, Mariam M., et al.
Publicado: (2017)

Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan
por: Chiang, Chun-Ju, et al.
Publicado: (2022)

Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature
por: Chou, Jen-Wei, et al.
Publicado: (2017)

Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
por: Cheng, Huei-Ru, et al.
Publicado: (2013)

Effects of 12-Week Progressive Sandbag Exercise Training on Glycemic Control and Muscle Strength in Patients with Type 2 Diabetes Mellitus Combined with Possible Sarcopenia
por: Chien, Yu-Hsuan, et al.
Publicado: (2022)

Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients
por: Hsu, Ching-Sheng, et al.
Publicado: (2013)

Liver regeneration accelerates hepatitis B virus‐related tumorigenesis of hepatocellular carcinoma
por: Teng, Chiao‐Fang, et al.
Publicado: (2018)

Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection
por: Yang, Tsai-Hsuan, et al.
Publicado: (2023)

Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir
por: Chen, Chien-Hung, et al.
Publicado: (2017)

Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers
por: Alzahrani, Faisal Mousa, et al.
Publicado: (2019)

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
por: Hoang, Joseph K., et al.
Publicado: (2016)

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
por: Huang, Shang-Chin, et al.
Publicado: (2023)

High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
por: Lin, Ching-Chung, et al.
Publicado: (2019)

Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort
por: Argirion, Ilona, et al.
Publicado: (2022)

Hepatitis B Virus X Upregulates HuR Protein Level to Stabilize HER2 Expression in Hepatocellular Carcinoma Cells
por: Hung, Chao-Ming, et al.
Publicado: (2014)

Autophagy Suppresses Tumorigenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma Through Degradation of MicroRNA-224
por: Lan, Sheng-Hui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lhe3vr2ul5e478bhq3ir25kvtq